Evidence map›Paper›PMID 33230678›Full record

ReviewPaediatric drugs2021

Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children.

Gregory L Holmes

Open access · greenAbstract readReview
In one paragraph

Review in Paediatric drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Medications, epilepsy and climate change: Added layers of complexity.British journal of clinical pharmacology · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Gregory L HolmesDepartment of Neurological Sciences, Larner College of Medicine, University of Vermont, Stafford Hall, 118C, Burlington, VT, 05405, USA. gregory.holmes@med.uvm.edu.ORCID http://orcid.org/0000-0002-3758-6055
University of Vermont · US

Funding

Cognitive Deficits After Experimental Febrile Seizures: Neurobiology & BiomarkersR01NS108296 · NINDS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BARAM, TALLIE Z., HOLMES, GREGORY L. · 2018 to 2022
$2.6M
Mechanisms of Cognitive Impairment Following Early-Life SeizuresR01NS108765 · NINDS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HOLMES, GREGORY L. · 2018 to 2022
$1.9M
NIH HHS NS108296NIH HHS NS108765NINDS NIH HHS R01 NS108296NINDS NIH HHS R01 NS108765
6 · The paper itself

Abstract

There is increasing recognition that epilepsy can be associated with a broad spectrum of comorbidities. While epileptic seizures are an essential element of epilepsy in children, there is a spectrum of neurological, mental health and cognitive disorders that add to the disease burden of childhood epilepsy resulting in a decreased quality of life. The most common comorbid conditions in childhood epilepsy include depression, anxiety, autism spectrum disorders, sleep disorders, attention deficits, cognitive impairment, and migraine. While epilepsy can result in comorbidities, many of the comorbidities of childhood have a bi-directional association, with the comorbid condition increasing risk for epilepsy and epilepsy increasing the risk for the comorbid condition. The bidirectional feature of epilepsy and the comorbidities suggest a common underlying pathological basis for both the seizures and comorbid condition. While recognition of the comorbid conditions of pediatric epilepsies is increasing, there has been a lag in the development of effective therapies partly out of concern that drugs used to treat the comorbid conditions could increase seizure susceptibility. There is now some evidence that most drugs used for comorbid conditions are safe and do not lower seizure threshold. Unfortunately, the evidence showing drugs are effective in treating many of the childhood comorbidities of epilepsy is quite limited. There is a great need for randomized, placebo-controlled drug trials for efficacy and safety in the treatment of comorbidities of childhood epilepsy.

Indexed as

AdolescentAnticonvulsantsChildChild, PreschoolComorbidityEpilepsyHumansMental DisordersNeuropsychiatryQuality of LifeSeizuresAnticonvulsants

Identifiers

PMID33230678
PMCPMC7899432
OpenAlexW3109692647

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.